Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 18 studies | 28% ± 11% | |
macrophage | 12 studies | 25% ± 9% | |
astrocyte | 11 studies | 34% ± 17% | |
ciliated cell | 10 studies | 24% ± 10% | |
glutamatergic neuron | 10 studies | 45% ± 27% | |
fibroblast | 10 studies | 20% ± 6% | |
type I pneumocyte | 9 studies | 26% ± 8% | |
GABAergic neuron | 9 studies | 44% ± 25% | |
microglial cell | 9 studies | 30% ± 9% | |
oligodendrocyte precursor cell | 9 studies | 34% ± 16% | |
oligodendrocyte | 8 studies | 30% ± 8% | |
epithelial cell | 7 studies | 34% ± 12% | |
pericyte | 7 studies | 19% ± 4% | |
interneuron | 6 studies | 47% ± 27% | |
dendritic cell | 6 studies | 24% ± 7% | |
neuron | 5 studies | 29% ± 9% | |
retinal ganglion cell | 5 studies | 32% ± 11% | |
amacrine cell | 5 studies | 24% ± 11% | |
retina horizontal cell | 5 studies | 22% ± 8% | |
adipocyte | 5 studies | 22% ± 3% | |
mast cell | 5 studies | 21% ± 6% | |
endothelial cell of lymphatic vessel | 5 studies | 28% ± 6% | |
smooth muscle cell | 5 studies | 24% ± 7% | |
CD16-negative, CD56-bright natural killer cell, human | 4 studies | 18% ± 1% | |
non-classical monocyte | 4 studies | 22% ± 6% | |
myeloid cell | 4 studies | 26% ± 5% | |
lymphocyte | 4 studies | 28% ± 6% | |
retinal rod cell | 4 studies | 20% ± 3% | |
natural killer cell | 4 studies | 19% ± 3% | |
monocyte | 4 studies | 21% ± 3% | |
basal cell | 4 studies | 29% ± 11% | |
goblet cell | 4 studies | 23% ± 13% | |
classical monocyte | 3 studies | 22% ± 3% | |
GABAergic interneuron | 3 studies | 33% ± 2% | |
granule cell | 3 studies | 21% ± 3% | |
B cell | 3 studies | 16% ± 0% | |
retinal bipolar neuron | 3 studies | 18% ± 2% | |
retinal cone cell | 3 studies | 18% ± 2% | |
retinal pigment epithelial cell | 3 studies | 29% ± 12% | |
GABAergic amacrine cell | 3 studies | 28% ± 12% | |
Mueller cell | 3 studies | 22% ± 5% | |
glycinergic amacrine cell | 3 studies | 22% ± 4% | |
abnormal cell | 3 studies | 22% ± 9% | |
ependymal cell | 3 studies | 34% ± 8% | |
alveolar macrophage | 3 studies | 26% ± 6% | |
type II pneumocyte | 3 studies | 19% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 3016.71 | 21 / 21 | 100% | 25.17 | 504 / 504 |
esophagus | 100% | 2238.23 | 1445 / 1445 | 100% | 23.18 | 183 / 183 |
lung | 100% | 3083.71 | 578 / 578 | 100% | 21.65 | 1155 / 1155 |
pancreas | 100% | 2058.91 | 328 / 328 | 100% | 23.19 | 178 / 178 |
stomach | 100% | 2681.95 | 359 / 359 | 100% | 22.47 | 286 / 286 |
breast | 100% | 2869.31 | 459 / 459 | 100% | 33.14 | 1117 / 1118 |
intestine | 100% | 2919.32 | 966 / 966 | 100% | 24.18 | 526 / 527 |
prostate | 100% | 2750.89 | 245 / 245 | 100% | 22.60 | 501 / 502 |
uterus | 100% | 2686.96 | 170 / 170 | 100% | 21.22 | 458 / 459 |
kidney | 100% | 2882.53 | 89 / 89 | 100% | 23.03 | 899 / 901 |
liver | 100% | 2114.41 | 226 / 226 | 100% | 18.17 | 405 / 406 |
brain | 100% | 2523.70 | 2635 / 2642 | 100% | 26.49 | 705 / 705 |
thymus | 100% | 3930.77 | 653 / 653 | 100% | 33.90 | 603 / 605 |
ovary | 100% | 2679.62 | 180 / 180 | 99% | 15.12 | 427 / 430 |
adrenal gland | 100% | 3630.72 | 258 / 258 | 99% | 23.44 | 228 / 230 |
skin | 100% | 2844.97 | 1808 / 1809 | 93% | 19.28 | 439 / 472 |
lymph node | 0% | 0 | 0 / 0 | 100% | 18.48 | 29 / 29 |
spleen | 100% | 3254.82 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 13.32 | 1 / 1 |
blood vessel | 100% | 2723.74 | 1334 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 2816.07 | 1203 / 1204 | 0% | 0 | 0 / 0 |
heart | 98% | 1485.21 | 845 / 861 | 0% | 0 | 0 / 0 |
muscle | 98% | 1051.24 | 786 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 12.05 | 44 / 45 |
peripheral blood | 79% | 1804.91 | 738 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 74% | 9.94 | 59 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0015031 | Biological process | protein transport |
GO_0099170 | Biological process | postsynaptic modulation of chemical synaptic transmission |
GO_0097352 | Biological process | autophagosome maturation |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0005764 | Cellular component | lysosome |
GO_0031902 | Cellular component | late endosome membrane |
GO_0005829 | Cellular component | cytosol |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0098794 | Cellular component | postsynapse |
GO_0005770 | Cellular component | late endosome |
GO_0030425 | Cellular component | dendrite |
GO_0080025 | Molecular function | phosphatidylinositol-3,5-bisphosphate binding |
GO_0035091 | Molecular function | phosphatidylinositol binding |
Gene name | SNX14 |
Protein name | Sorting nexin 14 Sorting nexin-14 |
Synonyms | |
Description | FUNCTION: Plays a role in maintaining normal neuronal excitability and synaptic transmission. May be involved in several stages of intracellular trafficking (By similarity). Required for autophagosome clearance, possibly by mediating the fusion of lysosomes with autophagosomes (Probable). Binds phosphatidylinositol 3,5-bisphosphate (PtdIns(3,5)P2), a key component of late endosomes/lysosomes . Does not bind phosphatidylinositol 3-phosphate (PtdIns(3P)) . . |
Accessions | A0A804HI47 A0A804HI30 ENST00000684319.1 A0A804HKD6 ENST00000682776.1 ENST00000684118.1 A0A804HJL8 ENST00000683643.1 D6RDA6 ENST00000514419.6 A0A804HKA3 A0A804HJ79 ENST00000683085.1 ENST00000418862.2 A0A804HKC6 H0Y926 ENST00000513865.5 ENST00000682660.1 ENST00000682939.1 ENST00000508658.6 A0A804HJ76 A0A804HJA7 A0A804HIM9 E2QRM8 ENST00000683898.1 A0A804HKY3 A0A804HL41 A0A804HKP6 ENST00000682455.1 ENST00000682057.1 ENST00000683481.1 Q9Y5W7 ENST00000681981.1 ENST00000682133.1 ENST00000683857.1 A0A804HIC6 A0A804HKZ1 ENST00000684422.1 ENST00000682412.1 A0A804HJZ4 A0A804HJ02 A0A804HJT4 A0A804HIK6 D6RJG9 A0A804HKN4 ENST00000683097.1 ENST00000682022.1 ENST00000683073.1 ENST00000683785.1 ENST00000683195.1 ENST00000684581.1 A0A804HID8 ENST00000683698.1 ENST00000684281.1 ENST00000684451.1 ENST00000683542.1 A0A804HLC7 ENST00000684680.1 A0A804HJF4 A0A804HL53 A0A804HJK3 A0A804HK24 A0A804HJD1 ENST00000682171.1 A0A804HIA1 D6RDH9 ENST00000505648.5 [Q9Y5W7-3] ENST00000684150.1 ENST00000683754.1 A0A804HIC5 ENST00000682854.1 A0A804HJW4 A0A804HIV6 ENST00000682738.1 ENST00000683726.1 A0A804HJC6 A0A804HLH9 A0A804HK55 ENST00000683873.1 ENST00000682464.1 ENST00000682174.1 ENST00000682694.1 ENST00000513869.2 A0A804HIR3 ENST00000683126.1 ENST00000683878.1 ENST00000682991.1 A0A804HHZ6 A0A804HJG1 A0A804HKJ3 D6RBA7 ENST00000346348.7 [Q9Y5W7-2] ENST00000684717.1 ENST00000682633.1 ENST00000683583.1 ENST00000682023.1 ENST00000682454.1 A0A804HIJ3 A0A804HJS3 ENST00000683880.1 A0A804HL44 A0A804HJ91 ENST00000684273.1 A0A804HI51 ENST00000682374.1 ENST00000682491.1 A0A804HKH6 ENST00000515216.6 ENST00000682995.1 A0A804HIW9 A0A804HJH5 A0A804HID3 A0A804HIZ9 ENST00000683577.1 ENST00000683458.1 ENST00000683196.1 ENST00000369635.7 A0A804HJ61 A0A804HHR7 ENST00000682682.1 ENST00000682878.1 A0A804HJI4 D6REK1 ENST00000684239.1 A0A804HKN0 A0A804HIX9 ENST00000684570.1 ENST00000682034.1 ENST00000682688.1 ENST00000683541.1 ENST00000682497.1 A0A804HHX8 A0A804HKT4 ENST00000683803.1 ENST00000314673.8 [Q9Y5W7-1] ENST00000509338.6 ENST00000684647.1 ENST00000684299.1 ENST00000683479.1 ENST00000369627.6 [Q9Y5W7-4] Q5JRQ0 A0A804HK22 |